Stephens Inc. AR Sells 617 Shares of Encompass Health Co. (NYSE:EHC)

Stephens Inc. AR reduced its stake in Encompass Health Co. (NYSE:EHC) by 19.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,500 shares of the company’s stock after selling 617 shares during the period. Stephens Inc. AR’s holdings in Encompass Health were worth $231,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of EHC. Creative Planning increased its holdings in shares of Encompass Health by 4.1% in the third quarter. Creative Planning now owns 19,086 shares of the company’s stock worth $1,844,000 after purchasing an additional 743 shares during the last quarter. V Square Quantitative Management LLC increased its stake in Encompass Health by 53.0% in the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after acquiring an additional 140 shares during the last quarter. First Citizens Bank & Trust Co. purchased a new stake in shares of Encompass Health during the 3rd quarter worth approximately $228,000. Raymond James & Associates boosted its position in shares of Encompass Health by 19.2% during the 3rd quarter. Raymond James & Associates now owns 160,545 shares of the company’s stock valued at $15,515,000 after acquiring an additional 25,907 shares during the last quarter. Finally, Copeland Capital Management LLC grew its holdings in shares of Encompass Health by 1.0% in the third quarter. Copeland Capital Management LLC now owns 1,284,550 shares of the company’s stock valued at $124,139,000 after purchasing an additional 12,433 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Insider Activity at Encompass Health

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the firm’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the transaction, the chief accounting officer now directly owns 69,164 shares in the company, valued at $6,798,129.56. This trade represents a 6.79 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 2.10% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on EHC shares. KeyCorp upped their price target on shares of Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Monday, February 10th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $110.00 price target on shares of Encompass Health in a report on Tuesday, February 11th. StockNews.com upgraded Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday. William Blair restated an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. Finally, Truist Financial reiterated a “buy” rating and issued a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Ten equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, Encompass Health currently has an average rating of “Buy” and a consensus target price of $107.67.

Encompass Health Trading Up 0.8 %

Shares of NYSE EHC opened at $100.91 on Monday. The business’s 50 day moving average price is $95.97 and its 200-day moving average price is $95.56. Encompass Health Co. has a fifty-two week low of $73.02 and a fifty-two week high of $104.55. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. The company has a market cap of $10.17 billion, a price-to-earnings ratio of 22.62, a PEG ratio of 1.18 and a beta of 0.90.

Encompass Health (NYSE:EHC) last released its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 18.06% and a net margin of 8.48%. On average, sell-side analysts expect that Encompass Health Co. will post 4.76 earnings per share for the current year.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.